Cd19-positive B-cell Malignancies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-05-16
Clinical Trial Update: UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies. [EARLY_Phase 1]
UTAA09 Injection is being evaluated in an early Phase 1 trial for CD19-positive relapsed or refractory B-cell malignancies, with patient rec…